Dealings in securities by a director and an associate of a director
Mediclinic International Limited
(Incorporated in the Republic of South Africa)
(Registration number: 1983/010725/06)
ISIN: ZAE000074142
JSE Share Code: MDC
NSX Share Code: MCI
("Mediclinic" or “the Company”)
DEALINGS IN SECURITIES BY A DIRECTOR AND AN ASSOCIATE OF A
DIRECTOR
In compliance with the Listings Requirements of the JSE Limited,
the following information is disclosed:
Director : Dr E de la H Hertzog (Chairman)
Company : Mediclinic International Limited
Date of transaction : 4 February 2016
Nature of transaction : Off market transfer of
securities to a company of which
Dr Hertzog is a director and
shareholder. He will hold an
indirect beneficial interest in
the shares transferred.
Class of securities : Ordinary shares
Number of securities : 80 567
Selling price : R123.00 per share
Total value of transaction : R9 909 741.00
Nature of interest : Direct beneficial
Clearance obtained : Yes
Director : Dr E de la H Hertzog (Chairman)
Associate : Mrs E Hertzog (Wife)
Company : Mediclinic International Limited
Date of transaction : 4 February 2016
Nature of transaction : Off market transfer of
securities by an associate of Dr
Hertzog to a company of which Dr
Hertzog is a director and
shareholder. He will hold an
indirect beneficial interest in
the shares transferred.
Class of securities : Ordinary shares
Number of securities : 550 274
Selling price : R123.00 per share
Total value of transaction : R67 683 702.00
Nature of interest : Dealings by an associate
Clearance obtained : Yes
Stellenbosch
5 February 2016
Mediclinic Offices, Strand Road, Stellenbosch 7600, South Africa
PO Box 456, Stellenbosch 7599, South Africa
Tel +27 (0)21 809 6500
Fax +27 (0)21 886 4037
Ethics Line: 0800 005 316
Website: www.mediclinic.com
Sponsor
RAND MERCHANT BANK (A division of FirstRand Bank Limited)
Date: 05/02/2016 11:53:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE').
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct,
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
information disseminated through SENS.